Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII–p38MAPK–pS249/T252RB Pathway
Li‐Yuan Yu‐Lee(The University of Texas MD Anderson Cancer Center), Sue-Hwa Lin(The University of Texas MD Anderson Cancer Center), Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), Francesc Posas(Institute for Research in Biomedicine), Pamela Villalobos(The University of Texas MD Anderson Cancer Center), Chad J. Creighton(Baylor College of Medicine), Kai‐Jie Yu(The University of Texas MD Anderson Cancer Center), Yu‐Chen Lee(China Medical University), Song-Chang Lin(The University of Texas MD Anderson Cancer Center), Eulàlia de Nadal(Universitat Pompeu Fabra), Bin Liu(UCSF Helen Diller Family Comprehensive Cancer Center), Jing Pan(Baylor College of Medicine), Tianhong Pan(The University of Texas MD Anderson Cancer Center), Guoyu Yu(The University of Texas MD Anderson Cancer Center), Gary E. Gallick(The University of Texas MD Anderson Cancer Center), Jaime Rodriguez‐Canales(National Cancer Institute)
Cited by 175
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k